Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Safety and Effectiveness of Transdermal Buprenorphine in Cancer Pain
- Conditions
- Cancer
- First Posted Date
- 2020-03-20
- Last Posted Date
- 2020-03-20
- Lead Sponsor
- Taiwan Mundipharma Pharmaceuticals Ltd.
- Target Recruit Count
- 83
- Registration Number
- NCT04315831
- Locations
- 🇨🇳
Chang Gung Memorial Hospital- Linko Branch, New Taipei City, Taiwan
A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain
- First Posted Date
- 2017-06-05
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Taiwan Mundipharma Pharmaceuticals Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT03176199
- Locations
- 🇨🇳
Changhua Christian Hospital, Chang-hua, Taiwan
🇨🇳Taichung Veterans General Hospital, Taichung, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
- First Posted Date
- 2017-06-05
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Taiwan Mundipharma Pharmaceuticals Ltd.
- Target Recruit Count
- 73
- Registration Number
- NCT03176121
- Locations
- 🇨🇳
Changhua Christian Hospital, Chang-hua, Taiwan
🇨🇳Chang Gung Memorial Hospital, Chiayi branch, Chiayi City, Taiwan
🇨🇳Chang Gung Memorial Hospital, Kaohsiung branch, Kaohsiung, Taiwan
Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain Patients
- Conditions
- PainCancer
- First Posted Date
- 2017-05-16
- Last Posted Date
- 2017-05-16
- Lead Sponsor
- Taiwan Mundipharma Pharmaceuticals Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT03155516
- Locations
- 🇨🇳
Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
🇨🇳Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan
A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- Taiwan Mundipharma Pharmaceuticals Ltd.
- Target Recruit Count
- 22
- Registration Number
- NCT03150602
- Locations
- 🇨🇳
Ntional Taiwan University Hospital, Taipei, Taiwan